Table 5.
PTEN scoring agreement for endometrioid (n=84) vs non-endometrioid (n=34) cases in the study set following independent performance of immunohistochemistry and scoring at MSKCC and MDACC. In this analysis, negative and heterogeneous categories have been combined into one category.
| MSKCC Interpretation | MDACC Interpretation | |||
|---|---|---|---|---|
| Non-Endometrioid | Endometrioid | |||
| Negative and Heterogeneous | Positive | Negative and Heterogeneous | Positive | |
| Negative | 9 | 2 | 57 | 3 |
| Positive | 2 | 21 | 4 | 20 |
| Weighted κ (95% CI) | 0.73 (0.49 – 0.98) | 0.79 (0.65 – 0.94) | ||
| Percent Agreement (95% CI) | 88% (73% – 97%) | 92% (84% – 97%) | ||